DIA 2017 Annual Meeting

Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-17-559-L04-P; CME 1.25; IACET 1.25; RN 1.25

Data from both premarket and postmarketing clinical trials and formal registries of medical products can be used to assess safety and effectiveness across the medical product life cycle. Sources outside of clinical trials, such as EHRs, can provide evidence of continued effectiveness when used in larger populations in the postmarketing setting. However, the lack of consistent outcome assessments is a potential barrier to evaluating safety and efficacy across the continuum of the product life cycle.

Learning Objectives

Discuss the gaps and challenges in the current environment resulting from a lack of outcomes standardization.

Chair

Richard Gliklich, MD

Speaker

Standardizing Outcomes for Patient Registries: Early Results From the Outcome Measures Framework Pilot Test
Elise Berliner, PhD

Panelist
Paul Stang, PhD, FISPE

Panelist
John H. Powers, III, MD, FACP